Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

VOLUME 8 , ISSUE 3 ( July-September, 2014 ) > List of Articles


Prenatal Diagnosis, Where and How: No Way Out?

Franco Borruto, Alain Treisser, Ciro Comparetto

Keywords : Amniocentesis,Cell-free fetal DNA,First trimester screening,Pregnancy,Prenatal diagnosis

Citation Information : Borruto F, Treisser A, Comparetto C. Prenatal Diagnosis, Where and How: No Way Out?. Donald School J Ultrasound Obstet Gynecol 2014; 8 (3):293-310.

DOI: 10.5005/jp-journals-10009-1368

License: CC BY-NC 4.0

Published Online: 01-09-2014

Copyright Statement:  Copyright © 2014; The Author(s).


How to cite this article

Borruto F, Treisser A, Comparetto C. Prenatal Diagnosis, Where and How: No Way Out? Donald School J Ultrasound Obstet Gynecol 2014;8(3):293-310.

PDF Share
  1. Techniques for early diagnosis of the abnormal fetus. Clin Perinatol 1994;21(4):723-741.
  2. Intrauterine fetal diagnosis for hematologic and other congenital disorders. Clin Lab Med 1999;19(1):239-253, vii-viii.
  3. Prenatal diagnosis and screening. Dermatol Clin 1987;5(1):17-41.
  4. Recent advances in noninvasive prenatal DNA diagnosis through analysis of maternal blood. J Obstet Gynaecol Res 2007;33(6):747-764.
  5. Prenatal screening of single-gene disorders from maternal blood. Am J Pharmacogenomics 2001;1(2):111-117.
  6. Fetal cells in maternal blood: their significance in noninvasive prenatal diagnosis and in etiologically determined diseases. Schweiz Med Wochenschr 1999;129(46):1740-1743.
  7. Circulating nucleic acids in plasma/serum. Pathology 2007;39(2):197-207.
  8. Isolation of fetal cells from the maternal circulation: prospects for the noninvasive prenatal diagnosis. Clin Chem Lab Med 2001;39(6):494-500.
  9. Clinical Sciences Reviews Committee of the Association of Clinical Biochemists. Cell-free nucleic acids in plasma, serum and urine: a new tool in molecular diagnosis. Ann Clin Biochem 2003;40(Pt 2):122-130.
  10. Application of fetal DNA in maternal plasma for noninvasive prenatal diagnosis. Expert Rev Mol Diagn 2002;2(1):32-40.
  11. Prenatal assessment of fetal chromosomal and genetic disorders through maternal plasma DNA analysis. Pathology 2012;44(2):69-72.
  12. Prenatal diagnosis: progress through plasma nucleic acids. Nat Rev Genet 2007;8(1):71-77.
  13. Noninvasive prenatal diagnosis of monogenic disorders. Expert Opin Biol Ther 2012;12 Suppl 1:S171-9.
  14. Noninvasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis. BMC Res Notes 2012 Sep 1;5(9):476.
  15. Recent progress in noninvasive prenatal diagnosis. Semin Fetal Neonatal Med 2008;13(2):57-62.
  16. Noninvasive prenatal diagnosis by massively parallel sequencing of maternal plasma DNA. Open Biol 2012; 2(6):120086.
  17. Post-genomics studies and their application to noninvasive prenatal diagnosis. Semin Fetal Neonatal Med 2008;13(2):91-98.
  18. SAFE, the special noninvasive advances in fetal and neonatal evaluation network: aims and achievements. Prenat Diagn 2008;28(2):83-88.
  19. The SAFE project: towards noninvasive prenatal diagnosis. Biochem Soc Trans 2009;37(Pt 2):460-465.
  20. Proteomic technologies for prenatal diagnostics: advances and challenges ahead. Expert Rev Proteomics 2009;6(1):87-101.
  21. Application of proteomics to prenatal screening and diagnosis for aneuploidies. Clin Chem Lab Med 2011;49(1):33-41.
  22. Second trimester serum tests for Down's syndrome screening. Cochrane Database Syst Rev 2012;6:CD009925.
  23. Noninvasive screening for chromosome abnormalities in young pregnant patients. Arch Gynecol Obstet 1992;252Suppl:S36-43.
  24. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998;352(9125):343-346.
  25. Role of ultrasound evaluation of nuchal translucency in prenatal diagnosis. Clin Exp Obstet Gynecol 2002;29(4):235-241.
  26. Ultrasound screening in pregnancy: advancing technology, soft markers for fetal chromosomal aberrations, and unacknowledged ethical dilemmas. Soc Sci Med 2003;56(10):2045-2057.
  27. Noninvasive prenatal testing for fetal sex determination: is ultrasound still relevant? Eur J Obstet Gynecol Reprod Biol 2013 Sep 11. pii: S0301-2115(13)00455-457.
  28. Role of the second-trimester ‘genetic sonogram’ for Down syndrome screen in the era of first-trimester screening and noninvasive prenatal testing. Prenat Diagn 2014 Jan 16.
  29. Down's syndrome screening in pregnancies after assisted reproductive techniques: an update. Reprod Biomed Online 2002;4(3):285-293.
  30. Cell-free fetal DNA and intact fetal cells in maternal blood circulation: implications for first and second trimester noninvasive prenatal diagnosis. Hum Reprod Update 2002;8(6):493-500.
  31. Noninvasive prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in maternal blood. Obstet Gynecol Sci 2013;56(2):58-66.
  32. Fetal cells in transcervical samples at an early stage of gestation. J Hum Genet 2001;46(3):99-104.
  33. Reliability of trans-cervical recovery of placental cells from the lower uterine pole using a minimally invasive procedure. Evidence based on fetal sexing and analysis of recovered cell populations. Early Hum Dev 1996;47Suppl:S99-102.
  34. Fetal cells in cervical mucus and maternal blood. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14(4):709-722.
  35. Fetal cells in the maternal blood and prenatal diagnosis. Gynecol Obstet Fertil 2000;28(11):785-791.
  36. Fetal cells in the mother: from genetic diagnosis to diseases associated with fetal cell microchimerism. Eur J Obstet Gynecol Reprod Biol 2000;92(1):103-108.
  37. Human fetal mesenchymal stem cells. Curr Stem Cell Res Ther 2006;1(3):371-386.
  38. Analysis of fetal blood cells in the maternal circulation: challenges, ongoing efforts, and potential solutions. Stem Cells Dev 2004;13(1):93-99.
  39. Isolating fetal cells in maternal circulation for prenatal diagnosis. Prenat Diagn 1994;14(13):1229-1242.
  40. Isolating fetal cells in the maternal circulation. Hum Reprod Update 1995;1(4):409-418.
  41. Prenatal diagnosis using fetal cells isolated from maternal peripheral blood: a review. Clin Obstet Gynecol 1996;39(4):801-813.
  42. Whole genome amplification from single cells in preimplantation genetic diagnosis and prenatal diagnosis. Eur J Obstet Gynecol Reprod Biol 2007;131(1):13-20.
  43. The introduction of QF-PCR in prenatal diagnosis of fetal aneuploidies: time for reconsideration. Hum Reprod Update 2004;10(6):541-548.
  44. New trends in noninvasive prenatal diagnosis: applications of dielectrophoresis-based Lab-on-a-chip platforms to the identification and manipulation of rare cells. Int J Mol Med 2008;21(1):3-12.
  45. Current and emerging techniques of fetal cell separation from maternal blood. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878(22):1905-1911.
  46. Novel approaches to manipulating foetal cells in the maternal circulation for noninvasive prenatal diagnosis of the unborn child. J Cell Biochem 2011;112(6):1475-1485.
  47. From karyotyping to array-CGH in prenatal diagnosis. Cytogenet Genome Res 2011;135(3-4):241-250.
  48. Microarray comparative genomic hybridization in prenatal diagnosis: a review. Ultrasound Obstet Gynecol 2012;40(4): 385-391.
  49. Amniotic fluid stem cells and fetal cell microchimerism. Trends Mol Med 2013;19(5):271-272.
  50. Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis. Ultrasound Obstet Gynecol 2013;41(6):610-620.
  51. Characterization of fetal cells from the maternal circulation by microarray gene expression analysis -could the extravillous trophoblasts be a target for future cell-based noninvasive prenatal diagnosis? Fetal Diagn Ther 2014;35:218-227.
  52. DNA-based prenatal diagnosis of heritable skin diseases. Arch Dermatol 1993;129(11):1455-1459.
  53. Prenatal detection of fetal Down's syndrome from maternal plasma. Lancet 2000;356(9244):1819-1820.
  54. Circulating fetal DNA in maternal plasma. Clin Chim Acta 2001;313(1-2):151-155.
  55. Fetal DNA in maternal plasma: application to noninvasive blood group genotyping of the fetus. Transfus Clin Biol 2001;8(3):306-310.
  56. Circulating (cell-free) nucleic acids – A promising, noninvasive tool for early detection of several human diseases. FEBS Lett 2007;581(5):795-799.
  57. Diagnostic developments involving cell-free (circulating) nucleic acids. Clin Chim Acta 2006;363(1-2):187-196.
  58. The use of cell-free fetal nucleic acids in maternal blood for noninvasive prenatal diagnosis. Hum Reprod Update 2009;15(1):139-151.
  59. Genetic analysis of the fetus using maternal blood. Gynecol Obstet Fertil 2004;32(7-8):646-650.
  60. Real-time PCR for prenatal and preimplantation genetic diagnosis of monogenic diseases. Mol Aspects Med 2006;27(2-3):176-191.
  61. Noninvasive prenatal diagnosis and determination of fetal Rh status. Semin Fetal Neonatal Med 2008;13(2):63-68.
  62. Prenatal typing of fetal DNA in cases of potential alloimmune haemolytic disease of the newborn: clinical benefit outweighs disadvantage. Br J Biomed Sci 1999;56(1):49-55.
  63. Fetal RhD genotyping from maternal plasma. Ann Med 1999;31(5):308-312.
  64. Noninvasive fetal RhD genotyping using maternal blood: time for use in all RhD negative pregnant women. Gynecol Obstet Fertil 2008;36(2):200-203.
  65. Noninvasive fetal RHD genotyping tests: a systematic review of the quality of reporting of diagnostic accuracy in published studies. Eur J Obstet Gynecol Reprod Biol 2009;142(2):91-98.
  66. Detection of circulating fetal nucleic acids: a review of methods and applications. J Clin Pathol 2009;62(4):308-313.
  67. Noninvasive prenatal diagnosis by single molecule counting technologies. Trends Genet 2009;25(7):324-331.
  68. Noninvasive diagnosis of fetal sex; utilisation of free fetal DNA in maternal plasma and ultrasound. Prenat Diagn 2006;26(7):598-603.
  69. Noninvasive prenatal diagnosis using cell-free fetal DNA technology: applications and implications. Public Health Genomics 2010;13(4):246-255.
  70. Noninvasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age. Semin Fetal Neonatal Med 2011;16(2):88-93.
  71. Uses of cell free fetal DNA in maternal circulation. Best Pract Res Clin Obstet Gynaecol 2012;26(5):639-654.
  72. The end of amniocentesis? From TriTest to PrenaTestTM. Donald School J Ultrasound Obstet Gynecol 2013;7(2):213-218.
  73. Noninvasive prenatal diagnosis: public and patient perceptions. Semin Fetal Neonatal Med 2008;13(2):109-112.
  74. Stress and anxiety associated with prenatal diagnosis. Best Pract Res Clin Obstet Gynaecol 2007;21(2):221-228.
  75. Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21. Am J Obstet Gynecol 2005;193(2):322-326.
  76. First trimester Down syndrome screening: public health implications. Semin Perinatol 2005;29(4):267-271.
  77. Noninvasive prenatal diagnosis: implications for antenatal diagnosis and management of highrisk pregnancies. Semin Fetal Neonatal Med 2008;13(2):84-90.
  78. Ethical aspects arising from noninvasive fetal diagnosis. Semin Fetal Neonatal Med 2008;13(2):103-108.
  79. Universal screening for inherited metabolic diseases in the neonate (and the fetus). J Matern Fetal Neonatal Med 2012;25(Suppl 5):4-6.
  80. Factors affecting the clinical use of noninvasive prenatal testing: a mixed methods systematic review. Prenat Diagn 2013;33(6):532-541.
  81. The obstetrician's view: ethical and societal implications of noninvasive prenatal diagnosis. Prenat Diagn 2006;26(7):631-634.
  82. Society of Obstetricians and Gynaecologists of Canada. Prenatal screening for fetal aneuploidy. J Obstet Gynaecol Can 2007;29(2):146-179.
  83. Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada; Prenatal Diagnosis Committee of the Canadian College of Medical Geneticists. Prenatal screening for fetal aneuploidy in singleton pregnancies. J Obstet Gynaecol Can 2011;33(7):736-750.
  84. Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada; Prenatal Diagnosis Committee of the Canadian College of Medical Geneticists. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies. J Obstet Gynaecol Can 2011;33(7):754-767.
  85. NSGC practice guideline: prenatal screening and diagnostic testing options for chromosome aneuploidy. J Genet Couns 2013;22(1):4-15.
  86. Genetics Committee of the SOGC. Cell-free fetal DNA in the maternal circulation and its future uses in obstetrics. J Obstet Gynaecol Can 2005;27(1):54-62.
  87. Noninvasive prenatal diagnosis of single gene disorders: how close are we? Semin Fetal Neonatal Med 2008;13(2):76-83.
  88. Current status in noninvasive prenatal detection of down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma. J Obstet Gynaecol Can 2013;35(2):177-181.
  89. Review: advances in noninvasive prenatal diagnosis. In Vivo 2013;27(2):165-170.
  90. Circulating fetal DNA: its origin and diagnostic potential – a review. Placenta 2004;25Suppl A:S93-S101.
  91. Fetal nucleic acids in maternal blood: the promises. Clin Chem Lab Med 2012;50(6):995-998.
  92. Noninvasive aneuploidy detection using free fetal DNA and RNA in maternal plasma: recent progress and future possibilities. Hum Reprod Update 2011;17(3):372-382.
  93. Genetic screening and diagnosis. Curr Opin Obstet Gynecol 2005;17(2):163-169.
  94. Noninvasive prenatal diagnosis: on the horizon. Pharmacogenomics 2003;4(2):191-200.
  95. Integration of genomics into medical practice. Discov Med 2013;16(89):241-248.
  96. Rapid methods for targeted prenatal diagnosis of common chromosome aneuploidies. Semin Fetal Neonatal Med 2011;16(2):81-87.
  97. Prenatal diagnosis: types and techniques. Early Hum Dev 2012;88(1):3-8.
  98. Noninvasive prenatal diagnosis of single-gene disorders from maternal blood. Gene 2012;504(1):144-149.
  99. Invasive procedures for prenatal diagnosis: any future left? Best Pract Res Clin Obstet Gynaecol 2012;26(5):625-638.
  100. DNA methylation based biomarkers: practical considerations and applications. Biochimie 2012;94(11):2314-2337.
  101. Noninvasive prenatal testing for Down syndrome. Semin Fetal Neonatal Med 2013 Nov 6. pii: S1744-165X(13)00095-4.
  102. New genetic testing in prenatal diagnosis. Semin Fetal Neonatal Med 2013 Dec 3. pii: S1744-165X(13)00097-8.
  103. Potential diagnostic consequences of applying noninvasive prenatal testing (NIPT): a population-based study from a country with existing first trimester screening. Ultrasound Obstet Gynecol 2014;43(3):265-271.
  104. Clinical implementation of noninvasive prenatal testing among maternal fetal medicine specialists. Prenat Diagn 2014 May;34(5):416-423.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.